Theraclion SA (EPA:ALTHE)
0.6300
+0.0060 (0.96%)
At close: Feb 20, 2026
Theraclion Market Cap
Theraclion has a market cap or net worth of €29.6 million as of February 20, 2026. Its market cap has increased by 197.49% in one year.
Market Cap
29.60M
Enterprise Value
33.01M
Revenue
1.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.63
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 29.60M, a decrease of -21.13%. That is a compound annual growth rate of -1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 29.60M | 4.65% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guerbet | 168.86M |
| Carvolix | 145.59M |
| Diagnostic Medical Systems | 33.93M |
| Novacyt | 27.29M |
| Implanet | 26.50M |
| Ikonisys | 25.67M |
| Biosynex | 18.34M |
| Mauna Kea Technologies | 13.28M |